Basic & Clinical Medicine ›› 2022, Vol. 42 ›› Issue (1): 56-61.doi: 10.16352/j.issn.1001-6325.2022.01.006

• Original Articles • Previous Articles     Next Articles

Effects of 5-lipoxygenase activating protein inhibitor MK886 on proliferation and apoptosis of human esophageal cancer cell lines

SHI Tie-wei1, LI Tian-zhu1, ZHOU Jing1, NA Ri-su1, SUN Qi1, XU Li-yan2, BAI Chun-ying1*   

  1. 1. Key Laboratory of Human Genetic Diseases in Inner Mongolia, School of Basic Medicine,Chifeng University, Chifeng 024000;
    2. Key Laboratory of Molecular Biology of High Incidence Tumor in Chaoshan Coastal Area of Guangdong Province, Medical College,Shantou University,Shantou 515000,China
  • Received:2021-03-18 Revised:2021-10-12 Online:2022-01-05 Published:2022-01-05
  • Contact: * 1053801210@qq.com

Abstract: Objective To investigate the effects of 5-lipoxygenase activating protein (FLAP) inhibitor MK886 on the proliferation and apoptosis of human esophageal carcinoma cell lines (KYSE-150 and TE-3) and to explore the potential mechanism. Methods KYSE-150 and TE-3 cells were treated with MK886(2.5,5,10,20,40 and 80 μmol/L). xCELLigence RTCA system was used to to detect the half maximal inhibitory concentration(IC50)of MK886. The expressions of proteins with apoptosis and autophagy were detected by Western blot and cell cycles were detected by flow cytometry. Results MK886 decreased the proliferation of human esophageal carcinoma cells(KYSE-150 and TE-3) (both P<0.05).IC50 of MK886 in KYSE-150 group was 29.11 μmol/L and in TE-3 group of 27.47 μmol/L.The proportion of G0/G1 phase was increased(both P<0.001)However, in the group treated with concentrations of MK886 50 μmol/L,G2/M phase was increased(P<0.05). The expression of cleaved-caspase-3 and LC-3A/B-Ⅱwere increased with MK886 (both P<0.001). Conclusions MK886 inhibits proliferation of human esophageal carcinoma cell lines and induces apoptosis.

Key words: esophageal carcinoma, proliferation, apoptosis, MK886, lipoxygenase

CLC Number: